Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1994 Nov;98(2):306–312. doi: 10.1111/j.1365-2249.1994.tb06142.x

Cellular mRNA expression of interferon-gamma, IL-4 and transforming growth factor-beta (TGF-beta) by rat mononuclear cells stimulated with peripheral nerve myelin antigens in experimental allergic neuritis.

J Zhu 1, E Mix 1, T Olsson 1, H Link 1
PMCID: PMC1534397  PMID: 7955537

Abstract

Experimental allergic neuritis (EAN) serves as a useful model for inflammation in the peripheral nervous system. To study the potential role of important immunoregulatory and effector cytokines in EAN, we examined the expression of mRNA for interferon-gamma (IFN-gamma), IL-4 and TGF-beta by in situ hybridization in lymph node and splenic cells cultured with bovine peripheral nerve myelin (BPM), P2 and P0 during the course of EAN in Lewis rats. Levels of IFN-gamma mRNA-expressing mononuclear cells (MNC) from lymph nodes and spleens roughly correlated with clinical status, consistent with a disease-promoting role for IFN-gamma. BPM, P0 and P2-reactive IFN-gamma mRNA-expressing T cells appeared in lymph nodes and spleen before onset of the disease, whereas a significant TGF-beta response to BPM, P2 and P0 was observed at lower levels than the IFN-gamma response and at onset of recovery, consistent with a disease down-regulating role of TGF-beta. IL-4 mRNA-expressing cells were found at levels similar to TGF-beta mRNA-expressing cells, and with the latest peak of the three cytokines examined. This result suggests that IL-4 may also suppress IFN-gamma expression at late recovery phase of EAN.

Full text

PDF
306

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. O., Hamilton T. A. Molecular transductional mechanisms by which IFN gamma and other signals regulate macrophage development. Immunol Rev. 1987 Jun;97:5–27. doi: 10.1111/j.1600-065x.1987.tb00514.x. [DOI] [PubMed] [Google Scholar]
  2. Adelmann M., Linington C. Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein. Neurochem Res. 1992 Sep;17(9):887–891. doi: 10.1007/BF00993264. [DOI] [PubMed] [Google Scholar]
  3. Assoian R. K., Fleurdelys B. E., Stevenson H. C., Miller P. J., Madtes D. K., Raines E. W., Ross R., Sporn M. B. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A. 1987 Sep;84(17):6020–6024. doi: 10.1073/pnas.84.17.6020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bengtsson B. O., Zhu J., Thorell L. H., Olsson T., Link H., Wålinder J. Effects of zimeldine and its metabolites, clomipramine, imipramine and maprotiline in experimental allergic neuritis in Lewis rats. J Neuroimmunol. 1992 Jul;39(1-2):109–122. doi: 10.1016/0165-5728(92)90180-s. [DOI] [PubMed] [Google Scholar]
  5. Dagerlind A., Friberg K., Bean A. J., Hökfelt T. Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry. 1992 Aug;98(1):39–49. doi: 10.1007/BF00716936. [DOI] [PubMed] [Google Scholar]
  6. Day M. J., Tse A. G., Puklavec M., Simmonds S. J., Mason D. W. Targeting autoantigen to B cells prevents the induction of a cell-mediated autoimmune disease in rats. J Exp Med. 1992 Mar 1;175(3):655–659. doi: 10.1084/jem.175.3.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Derynck R., Jarrett J. A., Chen E. Y., Eaton D. H., Bell J. R., Assoian R. K., Roberts A. B., Sporn M. B., Goeddel D. V. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature. 1985 Aug 22;316(6030):701–705. doi: 10.1038/316701a0. [DOI] [PubMed] [Google Scholar]
  8. Dijkema R., van der Meide P. H., Dubbeld M., Caspers M., Wubben J., Schellekens H. Cloning, expression, and purification of rat IFN-gamma. Methods Enzymol. 1986;119:453–464. doi: 10.1016/0076-6879(86)19065-3. [DOI] [PubMed] [Google Scholar]
  9. Duijvestijn A. M., Schreiber A. B., Butcher E. C. Interferon-gamma regulates an antigen specific for endothelial cells involved in lymphocyte traffic. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9114–9118. doi: 10.1073/pnas.83.23.9114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hughes R. A., Kadlubowski M., Gray I. A., Leibowitz S. Immune responses in experimental allergic neuritis. J Neurol Neurosurg Psychiatry. 1981 Jul;44(7):565–569. doi: 10.1136/jnnp.44.7.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hughes R. A., Powell H. C. Experimental allergic neuritis: demyelination induced by P2 alone and non-specific enhancement by cerebroside. J Neuropathol Exp Neurol. 1984 Mar;43(2):154–161. [PubMed] [Google Scholar]
  12. Johns L. D., Flanders K. C., Ranges G. E., Sriram S. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. J Immunol. 1991 Sep 15;147(6):1792–1796. [PubMed] [Google Scholar]
  13. Kadlubowski M., Hughes R. A., Gregson N. A. Experimental allergic neuritis in the Lewis rat: characterization of the activity of peripheral myelin and its major basic protein,P2. Brain Res. 1980 Feb 24;184(2):439–454. doi: 10.1016/0006-8993(80)90811-2. [DOI] [PubMed] [Google Scholar]
  14. Khalili-Shirazi A., Hughes R. A., Brostoff S. W., Linington C., Gregson N. T cell responses to myelin proteins in Guillain-Barré syndrome. J Neurol Sci. 1992 Sep;111(2):200–203. doi: 10.1016/0022-510x(92)90069-w. [DOI] [PubMed] [Google Scholar]
  15. Khoury S. J., Hancock W. W., Weiner H. L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med. 1992 Nov 1;176(5):1355–1364. doi: 10.1084/jem.176.5.1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lanzavecchia A. Antigen uptake and accumulation in antigen-specific B cells. Immunol Rev. 1987 Oct;99:39–51. doi: 10.1111/j.1600-065x.1987.tb01171.x. [DOI] [PubMed] [Google Scholar]
  17. Lindstrom J., Einarson B., Tzartos S. Production and assay of antibodies to acetylcholine receptors. Methods Enzymol. 1981;74(Pt 100):432–460. doi: 10.1016/0076-6879(81)74031-x. [DOI] [PubMed] [Google Scholar]
  18. Linington C., Izumo S., Suzuki M., Uyemura K., Meyermann R., Wekerle H. A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J Immunol. 1984 Oct;133(4):1946–1950. [PubMed] [Google Scholar]
  19. Linington C., Lassmann H., Ozawa K., Kosin S., Mongan L. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. Eur J Immunol. 1992 Jul;22(7):1813–1817. doi: 10.1002/eji.1830220721. [DOI] [PubMed] [Google Scholar]
  20. Lisak R. P., Saida T., Kennedy P. G., Saida K., Silberberg D. H., Leibowitz S. EAE, EAN and galactocerebroside sera bind to oligodendrocytes and Schwann cells. J Neurol Sci. 1980 Nov;48(2):287–296. doi: 10.1016/0022-510x(80)90207-5. [DOI] [PubMed] [Google Scholar]
  21. McKnight A. J., Barclay A. N., Mason D. W. Molecular cloning of rat interleukin 4 cDNA and analysis of the cytokine repertoire of subsets of CD4+ T cells. Eur J Immunol. 1991 May;21(5):1187–1194. doi: 10.1002/eji.1830210514. [DOI] [PubMed] [Google Scholar]
  22. Miller A., Lider O., Roberts A. B., Sporn M. B., Weiner H. L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):421–425. doi: 10.1073/pnas.89.1.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Milner P., Lovelidge C. A., Taylor W. A., Hughes R. A. P0 myelin protein produces experimental allergic neuritis in Lewis rats. J Neurol Sci. 1987 Jul;79(3):275–285. doi: 10.1016/0022-510x(87)90235-8. [DOI] [PubMed] [Google Scholar]
  24. Mosmann T. R., Coffman R. L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol. 1989;46:111–147. doi: 10.1016/s0065-2776(08)60652-5. [DOI] [PubMed] [Google Scholar]
  25. Mustafa M. I., Diener P., Höjeberg B., Van der Meide P., Olsson T. T cell immunity and interferon-gamma secretion during experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol. 1991 Feb;31(2):165–177. doi: 10.1016/0165-5728(91)90022-y. [DOI] [PubMed] [Google Scholar]
  26. Nomura K., Hamaguchi K., Ohno R., Hosokawa T., Negishi T., Yamashita T., Suzuki M., Uyemura K. Cell-mediated immunity to bovine P2 protein and neuritogenic synthetic peptide in experimental allergic neuritis. J Neuroimmunol. 1987 May;15(1):25–35. doi: 10.1016/0165-5728(87)90004-x. [DOI] [PubMed] [Google Scholar]
  27. Norton W. T., Poduslo S. E. Myelination in rat brain: method of myelin isolation. J Neurochem. 1973 Oct;21(4):749–757. doi: 10.1111/j.1471-4159.1973.tb07519.x. [DOI] [PubMed] [Google Scholar]
  28. Olsson T., Bakhiet M., Höjeberg B., Ljungdahl A., Edlund C., Andersson G., Ekre H. P., Fung-Leung W. P., Mak T., Wigzell H. CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule. Cell. 1993 Mar 12;72(5):715–727. doi: 10.1016/0092-8674(93)90400-k. [DOI] [PubMed] [Google Scholar]
  29. Peleman R., Wu J., Fargeas C., Delespesse G. Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells. J Exp Med. 1989 Nov 1;170(5):1751–1756. doi: 10.1084/jem.170.5.1751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Powrie F., Coffman R. L. Cytokine regulation of T-cell function: potential for therapeutic intervention. Trends Pharmacol Sci. 1993 May;14(5):164–168. doi: 10.1016/0165-6147(93)90202-u. [DOI] [PubMed] [Google Scholar]
  31. Raine C. S., Bornstein M. B. Experimental allergic neuritis. Ultrastructure of serum-induced myelin aberrations in peripheral nervous system cultures. Lab Invest. 1979 Apr;40(4):423–432. [PubMed] [Google Scholar]
  32. Schluesener H. J., Lider O. Transforming growth factors beta 1 and beta 2: cytokines with identical immunosuppressive effects and a potential role in the regulation of autoimmune T cell function. J Neuroimmunol. 1989 Oct;24(3):249–258. doi: 10.1016/0165-5728(89)90123-9. [DOI] [PubMed] [Google Scholar]
  33. Shull M. M., Ormsby I., Kier A. B., Pawlowski S., Diebold R. J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992 Oct 22;359(6397):693–699. doi: 10.1038/359693a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Skoskiewicz M. J., Colvin R. B., Schneeberger E. E., Russell P. S. Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med. 1985 Nov 1;162(5):1645–1664. doi: 10.1084/jem.162.5.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Swain S. L., McKenzie D. T., Weinberg A. D., Hancock W. Characterization of T helper 1 and 2 cell subsets in normal mice. Helper T cells responsible for IL-4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells. J Immunol. 1988 Nov 15;141(10):3445–3455. [PubMed] [Google Scholar]
  36. WAKSMAN B. H., ADAMS R. D. Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. J Exp Med. 1955 Aug 1;102(2):213–236. doi: 10.1084/jem.102.2.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Zhu J., Link H., Mix E., Olsson T., Huang W. X. Th1-like cell responses to peripheral nerve myelin components over the course of experimental allergic neuritis in Lewis rats. Acta Neurol Scand. 1994 Jul;90(1):19–25. doi: 10.1111/j.1600-0404.1994.tb02674.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES